menu search

Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

October 11, 2021, 12:30 pm

Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

October 11, 2021, 12:30 pm

Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

October 11, 2021, 12:30 pm

Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

October 11, 2021, 12:30 pm

Ocular therapeutix™ announces fda approval of supplemental new drug application (snda) for dextenza® (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use for the treatment of ocular itchi

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

October 11, 2021, 12:30 pm

Tutor perini jv bags $178m friant-kern canal middle reach capacity correction project

Tutor Perini Corp's (NYSE: TPC) joint venture with Brosamer & Wall, Inc. has secured a contract valued at ~$178 million from the U.S. Department o...

October 11, 2021, 7:14 am

Tutor perini jv bags $178m friant-kern canal middle reach capacity correction project

Tutor Perini Corp's (NYSE: TPC) joint venture with Brosamer & Wall, Inc. has secured a contract valued at ~$178 million from the U.S. Department o...

October 11, 2021, 7:14 am

Tutor perini jv bags $178m friant-kern canal middle reach capacity correction project

Tutor Perini Corp's (NYSE: TPC) joint venture with Brosamer & Wall, Inc. has secured a contract valued at ~$178 million from the U.S. Department o...

October 11, 2021, 7:14 am


Search within

Pages Search Results: